Secor Capital Advisors’s Idexx Laboratories IDXX Stock Holding History

Secor Capital Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-6,812	Closed	-$1.49M	–	490
2018 Q2	$1.49M	Buy	+6,812	New	+$1.4M	0.13%	244
2018 Q1	–	Sell	-1,702	Closed	-$266K	–	572
2017 Q4	$266K	Sell	1,702 -27,253	-94%	-$4.29M	0.01%	426
2017 Q3	$4.5M	Buy	28,955 +6,777	+31%	+$1.07M	0.43%	58
2017 Q2	$3.58M	Buy	+22,178	New	+$3.6M	0.32%	94
2016 Q4	–	Sell	-12,211	Closed	-$1.38M	–	550
2016 Q3	$1.38M	Buy	+12,211	New	+$1.29M	0.15%	202

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Secor Capital Advisors's IDXX Position: Q3 2018 in Review

Secor Capital Advisors sold out of Idexx Laboratories (IDXX) in Q3 2018, closing a stake of 6,812 shares — an estimated $1.49M sold.

Secor Capital Advisors first reported a position in IDXX in Q3 2016 and held it in 5 quarters. The position peaked at $4.5M in Q3 2017. 698 funds tracked by Wall St. Rank hold IDXX as of Q3 2018.

Secor Capital Advisors reported no remaining Idexx Laboratories position as of Q3 2018 after selling out during the quarter.
Secor Capital Advisors sold 6,812 Idexx Laboratories shares in Q3 2018, an estimated $1.49M.
Secor Capital Advisors first reported a position in Idexx Laboratories in Q3 2016 and held it in 5 quarters.
Secor Capital Advisors's Idexx Laboratories position peaked at $4.5M in Q3 2017.
698 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2018.

Based on Secor Capital Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.